The Asia Pacific Infertility Drugs Market would witness market growth of 7.0% CAGR during the forecast period (2022-2028).
Women who have trouble becoming pregnant or bringing a pregnancy to term are said to have impaired fecundity, which is a syndrome associated with infertility. In the United States, 1 in 5 heterosexual women between the ages of 15 and 49 who have never given birth are unsuccessful in becoming pregnant after a year of trying (infertility). Additionally, 26% of the women in this group report having trouble becoming pregnant or bringing a pregnancy to term (impaired fecundity).
Women who have given birth one or more times before are less likely to have infertility and reduced fecundity. Approximately 6% of married women in this demographic, who are between the ages of 15 and 49, are unable to conceive after a year of trying, and 14% have trouble becoming pregnant or bringing a baby to term.
The likelihood of a woman conceiving twins, triplets, or other multiples is increased by several reproductive medications. Multiple pregnancy might cause a woman's pregnancy to be more problematic. Premature birth is more likely in situations with multiple foetuses (too early). Premature infants are more likely to have health and developmental issues. Drugs for infertility become necessary as a result.
Among women of reproductive age, Polycystic Ovarian Syndrome (PCOS) is one of the most prevalent hormonal illnesses. Women who come with infertility often have been diagnosed with PCOS. As a result of the lack of a clear definition for the illness, the actual prevalence of PCOS is unknown. Worldwide, the prevalence of PCOS ranges from 2.2% to 26%. Prevalence rates in a few Asian nations range from 2% to 7.5% in China and 6.3% in Sri Lanka. Couples have pregnancy problems as a result of the growth of these disorders. As a result, the Asia Pacific region is seeing an increase in demand for infertility medications.
The China market dominated the Asia Pacific Infertility Drugs Market by Country in 2021; thereby, achieving a market value of $365.8 million by 2028. The Japan market is registering a CAGR of 6.3% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 7.6% during (2022 - 2028).
Based on End User, the market is segmented into Women and Men. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Specialty & Retail Pharmacy, and Online Pharmacy. Based on Drug Class, the market is segmented into Gonadotropins, Aromatase Inhibitors, Selective Estrogen Receptor Modulators (SERMs), Dopamine Agonists, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Infertility Drugs Market is Projected to reach USD 4.8 Billion by 2028, at a CAGR of 6.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Bayer AG, Novartis AG, Merck & Co., Inc., Pfizer, Inc., Teva Pharmaceuticals Industries Ltd., Sanofi S.A., Ferring Holdings SA, Organon & Co. and Mankind Pharma Ltd.
Scope of the Study
Market Segments Covered in the Report:
By End User
By Distribution Channel
- Hospital Pharmacy
- Specialty & Retail Pharmacy
- Online Pharmacy
By Drug Class
- Gonadotropins
- Aromatase Inhibitors
- Selective Estrogen Receptor Modulators (SERMs)
- Dopamine Agonists
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Bayer AG
- Novartis AG
- Merck & Co., Inc.
- Pfizer, Inc.
- Teva Pharmaceuticals Industries Ltd.
- Sanofi S.A.
- Ferring Holdings SA
- Organon & Co.
- Mankind Pharma Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Infertility Drugs Market, by End User
1.4.2 Asia Pacific Infertility Drugs Market, by Distribution Channel
1.4.3 Asia Pacific Infertility Drugs Market, by Drug Class
1.4.4 Asia Pacific Infertility Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Infertility Drugs Market by End-user
3.1 Asia Pacific Women Market by Country
3.2 Asia Pacific Men Market by Country
Chapter 4. Asia Pacific Infertility Drugs Market by Distribution Channel
4.1 Asia Pacific Hospital Pharmacy Market by Country
4.2 Asia Pacific Specialty & Retail Pharmacy Market by Country
4.3 Asia Pacific Online Pharmacy Market by Country
Chapter 5. Asia Pacific Infertility Drugs Market by Drug Class
5.1 Asia Pacific Gonadotropins Market by Country
5.2 Asia Pacific Aromatase Inhibitors Market by Country
5.3 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market by Country
5.4 Asia Pacific Dopamine Agonists Market by Country
5.5 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Infertility Drugs Market by Country
6.1 China Infertility Drugs Market
6.1.1 China Infertility Drugs Market by End-user
6.1.2 China Infertility Drugs Market by Distribution Channel
6.1.3 China Infertility Drugs Market by Drug Class
6.2 Japan Infertility Drugs Market
6.2.1 Japan Infertility Drugs Market by End-user
6.2.2 Japan Infertility Drugs Market by Distribution Channel
6.2.3 Japan Infertility Drugs Market by Drug Class
6.3 India Infertility Drugs Market
6.3.1 India Infertility Drugs Market by End-user
6.3.2 India Infertility Drugs Market by Distribution Channel
6.3.3 India Infertility Drugs Market by Drug Class
6.4 South Korea Infertility Drugs Market
6.4.1 South Korea Infertility Drugs Market by End-user
6.4.2 South Korea Infertility Drugs Market by Distribution Channel
6.4.3 South Korea Infertility Drugs Market by Drug Class
6.5 Singapore Infertility Drugs Market
6.5.1 Singapore Infertility Drugs Market by End-user
6.5.2 Singapore Infertility Drugs Market by Distribution Channel
6.5.3 Singapore Infertility Drugs Market by Drug Class
6.6 Malaysia Infertility Drugs Market
6.6.1 Malaysia Infertility Drugs Market by End-user
6.6.2 Malaysia Infertility Drugs Market by Distribution Channel
6.6.3 Malaysia Infertility Drugs Market by Drug Class
6.7 Rest of Asia Pacific Infertility Drugs Market
6.7.1 Rest of Asia Pacific Infertility Drugs Market by End-user
6.7.2 Rest of Asia Pacific Infertility Drugs Market by Distribution Channel
6.7.3 Rest of Asia Pacific Infertility Drugs Market by Drug Class
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.3 Novartis AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Merck & Co., Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Ferring Holdings SA
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research and Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Organon & Co.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Mankind Pharma Ltd.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
TABLE 1 Asia Pacific Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 2 Asia Pacific Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 3 Asia Pacific Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 4 Asia Pacific Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 5 Asia Pacific Women Market by Country, 2018 - 2021, USD Million
TABLE 6 Asia Pacific Women Market by Country, 2022 - 2028, USD Million
TABLE 7 Asia Pacific Men Market by Country, 2018 - 2021, USD Million
TABLE 8 Asia Pacific Men Market by Country, 2022 - 2028, USD Million
TABLE 9 Asia Pacific Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 10 Asia Pacific Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 11 Asia Pacific Hospital Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 12 Asia Pacific Hospital Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 13 Asia Pacific Specialty & Retail Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 14 Asia Pacific Specialty & Retail Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 15 Asia Pacific Online Pharmacy Market by Country, 2018 - 2021, USD Million
TABLE 16 Asia Pacific Online Pharmacy Market by Country, 2022 - 2028, USD Million
TABLE 17 Asia Pacific Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 18 Asia Pacific Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 19 Asia Pacific Gonadotropins Market by Country, 2018 - 2021, USD Million
TABLE 20 Asia Pacific Gonadotropins Market by Country, 2022 - 2028, USD Million
TABLE 21 Asia Pacific Aromatase Inhibitors Market by Country, 2018 - 2021, USD Million
TABLE 22 Asia Pacific Aromatase Inhibitors Market by Country, 2022 - 2028, USD Million
TABLE 23 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2018 - 2021, USD Million
TABLE 24 Asia Pacific Selective Estrogen Receptor Modulators (SERMs) Market by Country, 2022 - 2028, USD Million
TABLE 25 Asia Pacific Dopamine Agonists Market by Country, 2018 - 2021, USD Million
TABLE 26 Asia Pacific Dopamine Agonists Market by Country, 2022 - 2028, USD Million
TABLE 27 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
TABLE 28 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
TABLE 29 Asia Pacific Infertility Drugs Market by Country, 2018 - 2021, USD Million
TABLE 30 Asia Pacific Infertility Drugs Market by Country, 2022 - 2028, USD Million
TABLE 31 China Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 32 China Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 33 China Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 34 China Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 35 China Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 36 China Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 37 China Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 38 China Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 39 Japan Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 40 Japan Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 41 Japan Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 42 Japan Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 43 Japan Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 44 Japan Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 45 Japan Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 46 Japan Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 47 India Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 48 India Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 49 India Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 50 India Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 51 India Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 52 India Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 53 India Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 54 India Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 55 South Korea Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 56 South Korea Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 57 South Korea Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 58 South Korea Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 59 South Korea Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 60 South Korea Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 61 South Korea Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 62 South Korea Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 63 Singapore Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 64 Singapore Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 65 Singapore Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 66 Singapore Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 67 Singapore Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 68 Singapore Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 69 Singapore Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 70 Singapore Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 71 Malaysia Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 72 Malaysia Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 73 Malaysia Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 74 Malaysia Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 75 Malaysia Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 76 Malaysia Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 77 Malaysia Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 78 Malaysia Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 79 Rest of Asia Pacific Infertility Drugs Market, 2018 - 2021, USD Million
TABLE 80 Rest of Asia Pacific Infertility Drugs Market, 2022 - 2028, USD Million
TABLE 81 Rest of Asia Pacific Infertility Drugs Market by End-user, 2018 - 2021, USD Million
TABLE 82 Rest of Asia Pacific Infertility Drugs Market by End-user, 2022 - 2028, USD Million
TABLE 83 Rest of Asia Pacific Infertility Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 84 Rest of Asia Pacific Infertility Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 85 Rest of Asia Pacific Infertility Drugs Market by Drug Class, 2018 - 2021, USD Million
TABLE 86 Rest of Asia Pacific Infertility Drugs Market by Drug Class, 2022 - 2028, USD Million
TABLE 87 Key Information – Abbott Laboratories
TABLE 88 Key Information – Bayer AG
TABLE 89 Key Information – Novartis AG
TABLE 90 KEY INFORMATION - Merck & Co., Inc.
TABLE 91 Key Information – Pfizer, Inc.
TABLE 92 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 93 Key Information – Sanofi S.A.
TABLE 94 key information – Ferring Holdings SA
TABLE 95 Key Information – Organon & co.
TABLE 96 Key Information – Mankind Pharma Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Swot analysis: Abbott laboratories